135A Vrain Solution
- 3275
- +55+1.71%
Vrain Solution News
VRAI N - AI appearance inspection system is the mainstay, contributing to the labor-saving and automation of production sites.
VRain Solution <135A> provides AI solutions for the manufacturing industry. In their main AI system business, they sell their self-developed AI visual inspection system called 'Phoenix Vision/Eye.' By utilizing the system, their manufacturing clients can automate the inspection process on the production line without relying on human inspection for determining good or defective products. Their engineers
Brands that moved the day before part 1 Hokuetsu Corporation, Osaka Titanium Technologies, Awa Paper, etc.
<コード>Stock name 30-day closing price ⇒ Biawa Paper announced the day before 564 +80 medium-term management plan/mid-term vision, operating income plan for the fiscal year ending 26/3 billion yen (350 million yen for the fiscal year ending 24/3). A healthcare application operated by Tokyo Communications G ＜7359＞ 581 +79 subsidiary Parma has partnered with Otsuka Pharmaceutical's “Nature Made.” Is temporary popularity due to VRAIN ＜135A＞ 3460-235 good performance forecasts also a short-term outflow of funds? INTLOOP ＜9556＞ 30
Emerging Market Stock Digest: Kaifan continued to rise drastically for 3 days, and hotlinks temporarily stopped high
＜135A＞ Low price since listing for VRAIN 3460-235. While there are no noticeable transaction materials, sales are growing. It was newly listed on 2/22 and rose to 7890 yen at one point, but then it remained soft, and the public price (2990 yen) is perceived as an intention to lower the price. The main business is providing AI solutions for the manufacturing industry, and the operating profit forecast for the fiscal year ending 25/2 is also temporarily popular because good performance is expected to increase 51.8% from the previous fiscal year to 771 million yen
Backstage [stocks that moved, stocks that were made]
*Awa Paper (3896) announced the 564 +80 medium-term management plan and mid-term vision, and an operating profit plan of 700 million yen for the fiscal year ending 26/3 (350 million yen for the fiscal year ending 24/3). *Tokyo Communications G＜7359＞ 581 +79 The healthcare application operated by the subsidiary Parma has partnered with Otsuka Pharmaceutical's “Nature Made.” *Is temporary popularity due to VRAIN ＜135A＞ 3460-235 good performance forecast also a short-term outflow of funds? *INTLOOP ＜9556＞ 3005 +55 Edge AI Pro
VRAIN --- low price since listing, public price is about to drop, temporary popularity is also short-term outflow of funds
Low price since listing. While there are no noticeable transaction materials, sales are growing. It was newly listed on 2/22 and rose to 7890 yen at one point, but then it remained soft, and the public price (2990 yen) is perceived as an intention to lower the price. The main business is providing AI solutions for the manufacturing industry, and the operating profit forecast for the fiscal year ending 25/2 also temporarily became popular because good performance was expected to be 771 million yen, a 51.8% increase from the previous fiscal year, but sales dominance developed due to short-term outflows of funds
Volume change rate ranking (10:00) ~ VRAIN, first pan, etc. are ranked
* In the volume change rate ranking, it is possible to know the interest of market participants, such as shopping trends, by comparing the average turnover for the last 5 days with the turnover on the day of distribution. ■Top Volume Change Rate [as of 5/30 10:32] (Last 5 Day Average Volume Comparison) Stock Code Stock Name Volume 5 Day Average Volume Volume Change Rate ＜1369＞ One225 13383 137545.32 247.66% -0.02
Is VRAIN ranked, and is temporary popularity due to good performance forecasts also a short-term outflow of funds
VRAIN ＜135A＞ is in the ranking (as of 10:32). Low price since listing. While there are no noticeable transaction materials, sales are growing. It was newly listed on 2/22 and temporarily rose to 7890 yen, but then it remained soft, and it seems that the public price (2990 yen) is being perceived as an intention to lower the price. The operating profit forecast for the fiscal year ending 25/2 was temporarily popular because good performance was expected to be 771 million yen, an increase of 51.8% from the previous fiscal year, but sales dominance developed due to short-term outflows of funds
Vrain Solution: Extraordinary Report
Vrain Solution: Financial Report - Term 4 (2023/03/01 - 2024/02/29)
Vrain Solution: Confirmation Letter
Front market for high stop and low stop stocks
■Stop High＜3648＞AGS＜3987＞Ecomot ＜4179＞GeneXT＜5026＞Triple Eyes ■Stop Low＜135A＞VRAIN Solution＜9211＞F Code ＜9268＞Optimus Group※Includes Temporary Stop High/Low (sign value)
High stop/low stop-down stocks backstage
■Stop High＜1514＞Sumiseki Holdings＜1730＞Aso Home Creat ＜2349＞NID ＜3648＞AGS＜3905＞Data Section ＜4179＞Genex ＜4761＞Sakura KCS ＜5979＞Kanezou ＜9219＞Gicks ■Stop Yasu ＜135A＞VRAIN Solution＜2936＞Base Food ＜3558＞Jade Group ＜5595＞QPS Research Institute＜6814＞ Furuno Electric ＜7388＞
Weakness, depreciation of US stocks, and rise in long-term US interest rates are weighed
[Emerging Markets Individual Stock Strategy] Today's emerging markets are expected to develop softly. In the US stock market yesterday 15th, the Dow average depreciated by 248.13 dollars (-0.65%) to 37,735.11 dollars and continued to fall for 6 days. Retail sales for March exceeded expectations, and expectations for interest rate cuts receded. The rise in long-term interest rates weighed on stock prices, and since Israel suggested an intention to fight back against Iran, a further tense situation in the Middle East was feared, and the decline widened towards the end. I wonder if sales are dominant in today's emerging markets
J-Front, 24/2 operating profit up 125.9% to 43 billion yen, 25/2 forecast down 12.9% to 37.5 billion yen
The financial results for the fiscal year ending 2024/2 announced by J-Front ＜3086＞ were sales revenue of 407.0.06 billion yen, up 13.2% from the previous fiscal year, and operating profit of 43,048 billion yen, up 125.9% from the same period. Although the effects of the COVID-19 infection have been prolonged, major management numerical targets, including consolidated operating profit targets set in the mid-term plan, were generally achieved, and the financial position was improved by reducing interest-bearing debt, etc. As for the fiscal year ending 2025/2, sales revenue increased 3.6% from the previous fiscal year to 421.5 billion yen, and operating profit decreased 12.9%
Check out the disclosed information for [Tomorrow's Good and Bad Materials]! (Announced on 4/15)
[Good material] ---- ---- ■VRAIN Solutions [Tokyo Stock Exchange G] current fiscal year results increased 56% to update the highest profit for the 3rd consecutive term. ■MBS [TSE G] will carry out stock buybacks up to 100,000 shares (100 million yen in value), which is 1.35% of the number of issued shares (excluding company shares). The purchase period is from 4/16 to 25/5/15. ■Sumiseki Holdings' [Tokyo Stock Exchange S] is 37% higher than previous fiscal year results
J front, TKP, Shochiku, Toho (15 days)
*The above calendar is just a schedule and is subject to change due to company circumstances. ---------------------------------------4/15 (Mon) ＜135A＞VRAIN ＜1887＞Japan Land Development ＜2292＞S Foods ＜2337＞Ichigo ＜2338＞Quantum S ＜2404＞Tetsujin HD ＜2484＞Delivery Hall ＜2884＞Yoshimuraf
Minkab the Infonoid, ELEMENTS, etc.
＜135A＞VRAIN Solution Co., Ltd. Yusuke Minakawa Stock Ownership Ratio 68.78% → 67.14% Reporting Obligation Occurrence Date 2024/03/21 ＜142A＞Zinjib Co., Ltd. Sasaki Mitsuhide Stock Ownership Ratio -% → 58.00% Reporting Obligation Occurrence Date 2024/03/22 ＜4436＞Minkab The Infonoid Co., Ltd. Newton Investment Management Japan Co., Ltd. Stock Ownership Ratio
Emerging Market Split Candidate Stocks [Emerging Market Split Candidate Stocks]
Code Brand Name ＜4011＞Headwater ＜7095＞MacBeep ＜4051＞GMO-FG ＜4488＞AIINSIDE ＜6026＞GMOTECH ＜135A＞VRAIN ＜3496＞AZOME ＜9338＞INFORICH ＜5254＞ARENT ＜4417＞GROSEKYU ＜7386＞JWS
Analysis
Price Target
No Data
